Remove 2023 Remove Networking Remove Patients
article thumbnail

Atropos Health Launches Evidence Network to Back Its Physician Consult Service

MedCity News

Atropos Health — a company that delivers clinical data to physicians at the point of care to help them treat complex patients — recently launched a clinical advisory board and new evidence network.

article thumbnail

Digital Health Networks’ CINEHEALTH International Film and Video Festival Unveils Judging Panel

PM360

CINEHEALTH works to bring the community together through patient and HCP engagement using innovative storytelling. Extraordinary patient, caregiver, and HCP personalized experiences captured on film and video that are incredibly moving and thought-provoking.” “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

6 research and development life sciences predictions for 2023

pharmaphorum

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Patient choice will push sponsors toward operational excellence.

Safety 111
article thumbnail

CPHI Barcelona 2023 – Event preview

European Pharmaceutical Review

CPHI Barcelona, the renowned global pharma event, is set to take centre stage from 24 to 26 October 2023 at Fira Barcelona Gran Via, Spain. Uniting the global supply chain CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. Credit: CPHI What’s new for 2023?

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

MedTechVets Spring 2023 Networking Conference

MedTechVets

JUNE 21st – On May 23rd, MedTechVets held its Spring Networking Conference to mark the end of a successful Spring MTV Academy. Once you see patients, it is an impactful experience. Thank you to everyone who attended our Spring 2023 Networking Conference.

article thumbnail

Making ATMPs a reality for rare disease patients

European Pharmaceutical Review

The implementation of the EU’s Health Technology Assessment Regulation (HTAR) 1 will play a key role in shaping the patient access pathway for ATMPs such as cell and gene therapies. Currently, these therapies primarily target rare or ultra-rare diseases with small patient populations, which therefore limits clinical study sizes.